Ferring Pharmaceuticals

Saint-prex, Switzerland Founded: 1950 • Age: 76 yrs
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a Healthcare company based in Saint-prex (Switzerland) founded in 1950. Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. The company has 336 employees. Ferring Pharmaceuticals has completed 2 acquisitions, including Cytokine PharmaSciences and Rebiotix. Its website ferring.com draws about 40 thousand monthly visits. Its Indian entity Ferring Pharmaceuticals Private Limited reported revenue of ₹234 Cr. Its focus areas include Diversified Pharmaceuticals and Drugs.

Company details

Ferring Pharmaceuticals, based in Saint-prex, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Indian entity revenue
    ₹234 Cr

    FY 2024 · +7% YoY

  • Indian entity net profit
    ₹20.57 Cr

    FY 2024 · 9% margin

  • Indian entity EBITDA
    ₹31.19 Cr

    FY 2024 · 13% margin

  • Employee Count
    336
  • Investments & Acquisitions

Board of directors of Ferring Pharmaceuticals Private Limited (Ferring Pharmaceuticals)

Ferring Pharmaceuticals Private Limited is the primary company behind Ferring Pharmaceuticals. The board of Ferring Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Abhilash Mishra, appointed in 2025. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Abhilash Mishra
DIN 08745130
Additional Director26 Nov 202511 moFerring Pharmaceuticals Private Limited
Bhuvan Pratap Motta
DIN 11401157
Additional Director28 Nov 202511 moFerring Pharmaceuticals Private Limited

People of Ferring Pharmaceuticals

431 people are tracked at Ferring Pharmaceuticals (182 in leadership, 8 in board & advisors, 241 in team); the tracked headcount is 336.

NameRoleGroup
Angela Madeira
Head Of Portugal Commercial TeamLeadership
Per Falk
President & Chief Science OfficerLeadership
Ankit Baheti
Associate Director -formulation And Packaging DevelopmentLeadership
Rohit Somani
Associate Director - Financial Controller & Company SecretaryLeadership
Shirley Plews
Associate Director: Commercial ControllingLeadership
Lonnie Robinson
Sr. Finance Director, Planning And AnalysisLeadership
Martin Pram
Director, Global Device Innovation & Development, Global Pharmaceutical R&dLeadership
Matthew Green
Senior Director, Financial Planning & AnalysisLeadership
Pernille Maria Manuel
Senior Global Program Director, R&d ProjectsLeadership
Mauricio Espinel
Head Of Distributor Markets LatamLeadership
Rose Szabady
Senior DirectorLeadership
Bernard Fourie
Global Head Of Controlling R&dLeadership
Mario Esteves
Head Of Finance West Europe & CanadaLeadership
Nicolas Esmail
Head Of Global Science And Technology (msat)Leadership
Deborah L.
Marketing DirectorLeadership
Shawn Chen
China Finance DirectorLeadership
Elizna V.
Director, SMO Finance & ControllingLeadership
Deni Y. Martin
Country General ManagerLeadership
Salina Ströjby
Senior Director, Head Of GRA GastroLeadership
Mohan Sowlay
Director, Strategy, Business Development & New Product PlanningLeadership

411 more people are available in the full profile.

Premium access

Complete people profiles for Ferring Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Ferring Pharmaceuticals

Figures of Ferring Pharmaceuticals Private Limited, the primary company behind Ferring Pharmaceuticals, for FY 2024. Revenue was ₹234 Cr (+7% year on year). Net profit was ₹20.57 Cr (9% margin). EBITDA was ₹31.19 Cr (13% margin). Revenue has grown at a compounded annual rate of +12% over three years and +8% over five years.

  • ₹234 CrRevenue · FY 2024 · +7% YoY
  • ₹20.57 CrNet profit · 9% margin
  • ₹31.19 CrEBITDA · 13% margin
  • ₹1.26 CrPaid-up capital
  • 168Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ferring Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Ferring Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ferring Pharmaceuticals

Ferring Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cytokine PharmaSciences and Rebiotix.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Microbiota restoration therapies are developed for gastrointestinal infections.
rebiotix.comRoseville, United States2011Apr 2018••••
Controlled-release drug delivery products for women's health are developed.
cytokinepharmasciences.comKing Of Prussia, United States1993Oct 2011••••
Premium access

Complete acquisition details for Ferring Pharmaceuticals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Ferring Pharmaceuticals

3 dated milestones of Ferring Pharmaceuticals across 68 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ferring Pharmaceuticals is founded.
  2. Acquisition Acquires Cytokine PharmaSciences.
  3. Acquisition Acquires Rebiotix.

Web traffic of Ferring Pharmaceuticals

The website of Ferring Pharmaceuticals (ferring.com) receives about 39.6K visits a month and ranks #709,223 among all websites worldwide, #798 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    39.6K

    ▼ 22.1% vs previous month

  • Unique visitors
    18.9K

    per month

  • Global rank
    #709,223

    among all websites

  • Category rank
    #798

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Ferring Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ferringusa.com
ferringusa.com
100%
#1,992,264–
schering-plough.com
schering-plough.com
90%
–
bayer.com
90%
1.1M#52,188View details
pharmchoices.com
83%
#1,536,583View details
zellerag.ch
zellerag.ch
80%
#903,225–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 35 similar websites and full traffic analytics for Ferring Pharmaceuticals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 35 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ferring Pharmaceuticals

Premium access

Complete news archive for Ferring Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ferring Pharmaceuticals

Ferring Pharmaceuticals was founded in 1950.

Ferring Pharmaceuticals is headquartered in Saint-prex, Switzerland. It is registered at Saint-prex, Vaud, Switzerland.

Ferring Pharmaceuticals has 336 employees.

The primary company behind Ferring Pharmaceuticals, Ferring Pharmaceuticals Private Limited, reported revenue of ₹234 Cr for FY 2024, up 7% year on year.

Ferring Pharmaceuticals, based in Saint-prex, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Ferring Pharmaceuticals has made 2 acquisitions, including Cytokine PharmaSciences, and Rebiotix.

Ferring Pharmaceuticals operates through Ferring Pharmaceuticals Private Limited.

The legal entities of Ferring Pharmaceuticals currently have 2 directors, including Abhilash Mishra, Bhuvan Pratap Motta.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available